. 2014;27(88):s01-2.

Using a case study approach to document 'preferred practices' in mass drug administration for trachoma

Affiliations

¹ Trachoma Research Programme Officer, The Carter Center, Bahirdar, Ethiopia.
² Public Health Consultant, Kampala, Uganda.
³ Director Global Ophthalmology, Emory Eye Center, Emory University, Atlanta, GA, USA.
⁴ Director, Kilimanjaro Centre for Community Ophthalmology, Cape Town, South Africa.

Esmael Habtamu et al. Community Eye Health. 2014.

. 2014;27(88):s01-2.

¹ Trachoma Research Programme Officer, The Carter Center, Bahirdar, Ethiopia.
² Public Health Consultant, Kampala, Uganda.
³ Director Global Ophthalmology, Emory Eye Center, Emory University, Atlanta, GA, USA.
⁴ Director, Kilimanjaro Centre for Community Ophthalmology, Cape Town, South Africa.

No abstract available

Figures

1. World Health Organization. (2013). Global Alliance for the Elimination of Blinding Trachoma: progress report on the elimination of trachoma, 2012. Weekly Epidemiological Report, 24(88), 242–251. Retrieved from http://www.who.int/wer
1. Emerson P.M., Burton M., Solomon A.W., Bailey R., & Mabey D. (2006). The SAFE strategy for trachoma control: using operational research for policy, planning and implementation. Bulletin of the World Health Organization, 84, 613-619. - PMC - PubMed
1. International Trachoma Initiative. (2010). Zithromax® in the Elimination of Blinding Trachoma: A Program Manager's Guide (1st ed.). Atlanta, GA.
1. World Health Organization. (2010). Report of the 3rd Global Scientific Meeting on Trachoma. Baltimore, MD. Retrieved from http://www.who.int/blindness/publications/3RDGLOBALSCIENTIFICMEETINGONTR...
1. World Health Organization. (2006). Trachoma control: a guide for programme managers(1st ed.). Switzerland.